Government policies and their impact on the supply of medicines and medical devices at the MSP's Riobamba provincial general teaching hospital, period 2021-2023
DOI:
https://doi.org/10.55204/trc.v5i1.e448Keywords:
Government Policies, Hospital Supply, Health Management, Medicines, Medical DevicesAbstract
Introduction: Medical supply management emerges as a critical challenge in contemporary healthcare systems, especially following the profound impacts revealed during the health crisis. Objetive: In this context, this research analyzes the impact of government policies on the supply of medicines and medical devices at the Riobamba Provincial General Teaching Hospital during the 2021-2023 period. Methods: Through a longitudinal descriptive quantitative analysis, the evolution of supply and its relationship with three main government policies was examined: the Substitute Regulation (AGREEMENT 0051-2020), the Medicine Near Plan (Decree 378), and Ministerial Agreement 00103-2023. Results: The results revealed a significant transformation in supply levels: medical devices improved from 59.8% to 79.2%, while medications increased from 58.0% to 68.3%. A strong correlation was found between policy implementation and supply levels (r=0.756 for medicines and r=0.823 for devices), demonstrating the positive impact of government interventions. Budget execution reached historic levels of 100% for devices and 94% for medicines in 2022, demonstrating significant improvement in management efficiency. Conclusions: The findings suggest that sequential and adaptive policy implementation can substantially improve medical supply management, although opportunities persist to consistently reach the 90% target established by the MSP.
Downloads
References
desentralizada de compra SERCOP (2023).
Acuerdo Ministerial Nro. 000080-2022. Aprovisamiento de medicamentos e insumos médicos (2022).
American Society of Addiction Medicine. (2024). Public Policy Statement on Government Strategies to Foster Ethical Addiction Treatment. ASAM, 1-16.
Beck, M., & Buckley, J. (2022). Managing pharmaceutical shortages during the COVID pandemic: An exploratory analysis of European collective and national government responses. The Journal of Medicine Access, 6, 27550834221123425. https://doi.org/10.1177/27550834221123425
Emami, F., & Cheraghali, A. M. (2022). Policies and measures implemented to reduce the impact of international sanctions on Iran’s pharmaceutical sector. Research in Pharmaceutical Sciences, 17(3), 274-283. https://doi.org/10.4103/1735-5362.343081
Federal Drugs American. (2024). Medical Device Supply Chain and Shortages [Https://www.fda.gov/medical-devices/medical-device-safety/medical-device-supply-chain-and-shortages].
Ivama-Brummell, A. M., Pingret-Kipman, D., Louly, P. G., & Andrade, R. R. (2022). Medicines regulation, pricing and reimbursement in Brazil. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 13(1), 769. https://doi.org/10.30968/rbfhss.2022.131.0769
Jones, Y., & Kaczmarek, S. (2024). Federal Regulation: Selected Emerging Technologies Highlight the Need for Legislative Analysis and Enhanced Coordination. US. Government Accountability Office. https://www.gao.gov/products/gao-24-106122
Li, S. (2022). Ensuring Equitable Access to Affordable Prescription Medications. American Public Health Association, 1-16.
Limb, M. (2020). Drug suppliers are told to replenish stockpiles for Brexit and further pandemic this winter. BMJ, 370, m3104. https://doi.org/10.1136/bmj.m3104
López Ullauri, V. G., Chasipanta Avalos, M. E., Campoverde Ávila, A. E., & Pavón Rosero, L. E. (2021). Impacto por COVID-19 en Ecuador y planteamiento de una propuesta de política pública de prevención. Anatomía Digital, 4(4), 97-111. https://doi.org/10.33262/anatomiadigital.v4i4.1911
Maldonado Dávila, F. X. (2023). Estudio del complejo médico industrial en Ecuador. Análisis de 2008 a 2017 [Doutorado Direto em Saúde na Comunidade, Universidade de São Paulo]. https://doi.org/10.11606/T.17.2023.tde-10082023-101748
Maureen, M. (2024). Navigating Regulatory Changes in Specialty Drug Distribution. Complete Compliance Solutions LCC. https://www.complisolutions.com/post/regulatory-changes-in-specialty-drug-distribution
National Academies of Sciences Engineering, and Medicine. (2017). Communities in Action: Pathways to Health Equity. 6 Policies to support community solutions. 335-386. https://doi.org/10.17226/24624
Reglamento sustitutivo para la gestión del suministro de medicamentos y dispositivos médicos y control administrativoinanciero, 00051-2020 (2020).
Rodríguez Guerra, A., Villafuerte Garzón, C., & Ríos Quiñónez, M. B. (2023). Revisión de literatura de la industria farmacéutica: Establecimientos tipo “Drugstore” en el Ecuador: Literature review of the pharmaceutical industry: Drugstore establishments in Ecuador. RES NON VERBA REVISTA CIENTÍFICA, 13(2), 75-94. https://doi.org/10.21855/resnonverba.v13i2.829
Tenorio-Mucha, J., Lazo-Porras, M., Zafra, J., Ewen, M., & Beran, D. (2022). Using government data to understand the use and availability of medicines for hypertension and diabetes: Lessons from Peru. Journal of Pharmaceutical Policy and Practice, 15(1), 86. https://doi.org/10.1186/s40545-022-00481-5
World Health Organization. (2023). Quality and safety regulations [Oficial]. Health products policy and standards. https://www.who.int/teams/health-product-policy-and-standards/assistive-and-medical-technology/medical-devices/regulations
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Hernán Gabriel Cajo Riofrio, Omar Patricio Negrete Costales
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. They only give to the magazine Tesla Revista Científica the right to the first publication of this. Since Tesla Revista Científica is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself. Tesla Revista Científica undertakes not to make commercial use of the texts it receives and/or publishes.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
